CR 513S Business Processes and Contemporary Concerns in Pharmaceutical R & D 3.0 Credits
Bringing a new compound or device through a successful product launch in the bio-pharma or device industry is hugely expensive. Failures occur when information and business processes are inadequately used or inappropriately applied. This course will provide an overview of the processes most critical to launch from both clinical and business perspectives. Students will understand the R and D process as if they were participating in development and launch of new compounds, devices (including diagnostics), and biosimilars.
College/Department: COM School of Biomedical Sciences Professional Studies Repeat Status: Not repeatable for credit
In order to graduate, all students must pass three writing-intensive courses after their freshman year. Two writing-intensive courses must be in a student's major. The third can be in any discipline. Students are advised to take one writing-intensive class each year, beginning with the sophomore year, and to avoid “clustering” these courses near the end of their matriculation. Transfer students need to meet with an academic advisor to review the number of writing-intensive courses required to graduate.
For additional information, and an up-to-date list of the writing-intensive courses being offered, students should check the Drexel University Writing Center page